Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px
Document › Details

Kuros Biosciences Ltd.. (12/3/19). "Press Release: Kuros Announces Final Result of Capital Increase – Total Gross Proceeds of CHF 12.5 Million Raised [Not for US, UK, AU, et al.]". Schlieren.

Organisations Organisation Kuros Biosciences AG (SIX: KURN)
  Group Kuros (Group)
  Organisation 2 SIX Swiss Exchange AG
Products Product biomaterials
  Product 2 investment banking
Index term Index term Kuros–SEVERAL: investment, 201911–201912 capital increase CHF12.5m with 6.405m new registered shares at CHF1.95/share
Persons Person Grau, Michael (Proteros 201405– CFO before Correvio + Ingenium 200502– CFO + MorphoSys)
  Person 2 Herklots, Hans (LifeSci 201805 LifeSci Advisors before Carpicorn One + TiGenix)
     


   
Record changed: 2019-12-15

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

More documents for Kuros (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px




» top